Improving Global Access to Life Changing Therapies

Strategically Plan, Launch & Scale Global Early Access Programs to Deliver Earlier Patient Access While Navigating Complex Regulatory, Supply & Operational Hurdles

Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping timelines, evidence generation, and patient access across global markets.

The 5th Operationalise: Early Access Programmes Summit Europe is built for the teams responsible for turning that strategy into execution. As regulatory expectations shift, reimbursement timelines extend, and programmes scale globally, organisations must make more decisions, earlier, and with greater consequence.

This is the only European forum dedicated to the operational reality of early access - bringing together 140+ leaders across Medical Affairs, Access, Regulatory, Clinical Operations, and Supply to share how programmes are being designed, adapted, and delivered in practice.

Whether you are building your first programme, scaling across regions, or managing a global access portfolio, this is your opportunity to benchmark your approach, challenge your assumptions, and leave with the insight needed to make smarter decisions and deliver earlier, sustainable access for patients in 2026 and beyond.

It was inspiring to see such a broad spectrum of expertise come together in one forum, fostering meaningful dialogue and actionable insights

Associate Director & Co-Ordinator, Early Access Care  

EAC

The open exchange of best practices among high caliber experts in the fields is a standard in this conference series. The prominent presence of the patient caregivers is reminding us all why it is important to work and continuing building this space

Patient Access Programme & Supply Lead, Roche  

Roche

Valuable information sharing via well experienced speakers and open discussions both on best but also worst practices…

EAP & Patient Support Services Director, ACADIA Pharmaceuticals  

ACADIA - 5th Operationalise_ Early Access Programmes Europe

Explore the Full Event Guide

  • Get a Full Overview of the Agenda, Speakers, and Session Topics in One Place
  • Share Easily With Your Team to Assess and Mobilise Interest
  • Discover Unrivalled Networking Opportunities With 140+ Leaders Across Medical Affairs, Regulatory, Clinical Operations, and Supply
  • Explore Attendee Benefits, Exclusive Event Insights and Anticipated Audience Metrics
  • Learn More About Europe’s Only Forum Dedicated to the Operational Reality of Early Access
OEAPS E Brochure

What To Expect

140+

Early Access Leaders

25+

Expert Speakers

8+

Hours of Networking

6

Interactive Workshops

1

Dedicated Community

2026 Partners

OEAP Brochure image

Attending Companies Include

Jazz Pharmaceuticals Logo
Novo Nordisk Logo
Novartis Logo
AstraZeneca - 5th Operationalise_ Early Access Programmes Europe
BeOne Medicines - 5th Operationalise_ Early Access Programmes Europe
Bristol Myers Squibb - 5th Operationalise_ Early Access Programmes Europe
Biogen - 5th Operationalise_ Early Access Programmes Europe
ACADIA - 5th Operationalise_ Early Access Programmes Europe
Eisai - 5th Operationalise_ Early Access Programmes Europe
Panel Discussion
Explore the Agenda

Discover exactly how leading teams are solving the hardest Early Access challenges - from pathway selection and global delivery to data, supply, and long-term sustainability.

Panel Discussion
Partner With Us

Position your solutions in front of decision-makers actively looking to scale and optimise Early Access Programmes, and become a trusted partner in delivering access worldwide.

Networking
Join Early Access Leaders

Connect with the EAP community shaping how access is delivered today, exchange real challenges, and learn directly from peers running programmes across global markets.